Sandra M. Swain, MD

Clinical Expertise

Sandra M. Swain, MD has an international reputation as a leading authority both in the emergent field of inflammatory breast cancer treatment and in the treatment of early breast cancer.

Practice Focus

• Adjuvant therapy of breast cancer
• Molecular-targeted therapy for advanced and inflammatory breast cancer

Education

• BA from University of North Carolina, Chapel Hill, NC
• MD from University of Florida, Gainesville, FL

Residency

• Vanderbilt University in Nashville, TN

Fellowship

• Clinical Associate, Medical Breast Cancer Section, Medicine Branch, Division of Cancer Treatment, National Cancer Institute, Bethesda, MD
• Clinical Associate, Navy Medical Oncology Branch, Division Cancer Treatment, National Cancer Institute, Bethesda, Maryland

Credentialed Areas

• Board Certification, National Board of Medical Examiners
• Board Certification, American Board of Internal Medicine
• Board Certification, Medical Oncology

Honors, Awards & Society Memberships

• Mentor of Merit and as a Distinguished Clinical Teacher at the National Institutes of Health (Bethesda, Md.).
• Best Doctors in America, The 318 Top Cancer Specialists for Women (Good Housekeeping Magazine)
• NCI Outstanding Mentor Award (Nominee), 2001
• NIH Merit Award, 2001
• NCI Mentor of Merit, 2002
• “Top Doctors”, Washingtonian Magazine, 2002
• NCI Mentor of Merit, 2002, 2003, 2005
• NIH Distinguished Clinical Teacher’s Award (Nominee), 2005
• Finalist: NIH Clinical Center: Distinguished Clinical Teacher’s Award, 2005
• Breast Cancer Research and Treatment, 1992 – Editorial Board
• Journal National Cancer Institute, , 1992 – Editorial Board
• Investigational New Drugs, 1995 – Editorial Board
• Susan G. Komen Breast Cancer Foundation, 2998-2006, Medical Advisory Board, Medical Editor website, Breast Health Advisory Counsel, Clinical Trials Initiatve Advisory Group,
• American Society of Clinical Oncology, Member, Board Member 2008-2011, Education Chair 2007
• National Surgical Adjuvant Breast and Bowel Project, Breast Committee Vice-Chair and Board of Directors.
• National Accreditation Program for Breast Cancer (NAPBC), Board Member
• American Association for Cancer Research, Member
• American Society for Clinical Oncology, Member

Additional Training, Education & Research

• Designed, implemented, and published more than 20 clinical trials serving as principal investigator in most
• Principal Investigator of three Phase III adjuvant breast cancer trials through the NSABP
• More than 150 published articles in such prominent medical journals as the Journal of Clinical Oncology, Clinical Cancer Research, Clinical Breast Cancer and the Journal of the National Cancer Institute and editorials in New England Journal of Medicine and Journal of Clinical Oncology.
• Received Academic/Community Partnership grant “Breaking Down Barriers” from Komen For the Cure 2008-2011 to enhance treatment and minority recruitment in clinical trials

Back to Our Doctors